Journal
FRONTIERS IN PHARMACOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.950314
Keywords
pentoxifylline; muscle mechanical hyperalgesia; cytokine; oxidative stress; glial cells
Categories
Ask authors/readers for more resources
In this study, the researchers investigated the effect of pentoxifylline (Ptx) on delayed-onset muscle soreness (DOMS) in untrained mice exposed to intense acute swimming exercise. They found that Ptx treatment reduced mechanical hyperalgesia caused by intense acute swimming in a dose-dependent manner. Ptx also inhibited neutrophil recruitment, oxidative stress, and cytokine production in the muscle tissue and spinal cord, as well as reduced glial cell activation in the spinal cord. These findings suggest that Ptx can alleviate pain in DOMS by targeting peripheral and spinal cord mechanisms.
In this study, we pursue determining the effect of pentoxifylline (Ptx) in delayed-onset muscle soreness (DOMS) triggered by exposing untrained mice to intense acute swimming exercise (120 min), which, to our knowledge, has not been investigated. Ptx treatment (1.5, 4.5, and 13.5 mg/kg; i.p., 30 min before and 12 h after the session) reduced intense acute swimming-induced mechanical hyperalgesia in a dose-dependent manner. The selected dose of Ptx (4.5 mg/kg) inhibited recruitment of neutrophils to the muscle tissue, oxidative stress, and both pro- and anti-inflammatory cytokine production in the soleus muscle and spinal cord. Furthermore, Ptx treatment also reduced spinal cord glial cell activation. In conclusion, Ptx reduces pain by targeting peripheral and spinal cord mechanisms of DOMS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available